Updated Jul 17, 2026
Milhous Alison Tjosvold is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Alison Tjosvold Milhous is listed as an insider of VivoSim Labs, INC. (VIVS) in an SEC filing (CIK 0001824808) dated January 30, 2026. The filing reports no equity transactions (Total purchases: $0; Total sales: $0). VivoSim Labs is described as a biotechnology company focused on FXR314 for inflammatory bowel disease and related liver toxicology screening and research services; the company appears to be connected to Organovo Holdings Inc. in its corporate history.
| Role | Insider |
|---|---|
| Notability | 35/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-01-30 | VIVS | VivoSim Labs, INC. | A — Grant or award | 15.0K | $0.00 |
Alison Tjosvold Milhous is listed as an insider of VivoSim Labs, INC. (VIVS) in an SEC filing (CIK 0001824808) dated January 30, 2026. The filing reports no equity transactions (Total purchases: $0; Total sales: $0). VivoSim Labs is described as a biotechnology company focused on FXR314 for inflammatory bowel disease and related liver toxicology screening and research services;…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Milhous Alison Tjosvold profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.